It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 01733cam a22003854a 4500
001 2004027338
003 DLC
005 20100515082143.0
008 041116s2004 nyua b 101 0 eng
010 $a 2004027338
020 $a157331529X (cloth : alk. paper)
020 $a1573315303 (pbk. : alk. paper)
035 $a(DNLM)101234205
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aQ11$b.N5 vol. 1035$aRC394.D35
060 10 $aW1$bAN626YL v.1035 2004
060 10 $aWL 359$bP967 2004
082 00 $a500 s$a616.8/3$222
245 00 $aProtective strategies for neurodegenerative diseases /$cedited by Debomoy K. Lahiri.
260 $aNew York, N.Y. :$bNew York Academy of Sciences,$c2004.
300 $axiii, 356 p. :$bill. ;$c24 cm.
440 0 $aAnnals of the New York Academy of Sciences ;$vv. 1035
504 $aIncludes bibliographical references and index.
505 0 $aAlzheimer's disease -- Antioxidants and NSAIDs as neuroprotective strategies -- Inflammation and neurodegenerative diseases -- Complement and neurodegenerative diseases -- Melatonin and neuroprotection -- Parkinson's disease -- Therapeutic strategies and pharmacological manipulation.
650 0 $aNervous system$xDegeneration$xPrevention$vCongresses.
650 0 $aNeuroprotective agents$vCongresses.
650 12 $aNeurodegenerative Diseases$xdrug therapy.
650 12 $aNeurodegenerative Diseases$xprevention & control.
650 22 $aAnti-Inflammatory Agents$xtherapeutic use.
650 22 $aAntioxidants$xtherapeutic use.
650 22 $aModels, Animal.
650 22 $aNeuroprotective Agents$xtherapeutic use.
700 1 $aLahiri, Debomoy K.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip053/2004027338.html